A detailed history of J. Goldman & CO LP transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, J. Goldman & CO LP holds 135,000 shares of APLT stock, worth $117,450. This represents 0.04% of its overall portfolio holdings.

Number of Shares
135,000
Previous 337,500 60.0%
Holding current value
$117,450
Previous $1.58 Million 27.22%
% of portfolio
0.04%
Previous 0.05%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$2.25 - $7.4 $329,382 - $1.08 Million
146,392 New
146,392 $995,000

Others Institutions Holding APLT

About Applied Therapeutics Inc.


  • Ticker APLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,020,700
  • Market Cap $41.8M
  • Description
  • Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...
More about APLT
Track This Portfolio

Track J. Goldman & CO LP Portfolio

Follow J. Goldman & CO LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

News

Stay updated on J. Goldman & CO LP with notifications on news.